PMS42 Cost-Utility of Tocilizumab Monotherapy in Methotrexate Intolerant/Contra-Indicated, Moderate/Severe Rheumatoid Arthritis Patients in Portugal

Nov 1, 2012, 00:00
10.1016/j.jval.2012.08.1397
https://www.valueinhealthjournal.com/article/S1098-3015(12)03110-5/fulltext
Title : PMS42 Cost-Utility of Tocilizumab Monotherapy in Methotrexate Intolerant/Contra-Indicated, Moderate/Severe Rheumatoid Arthritis Patients in Portugal
Citation : https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(12)03110-5&doi=10.1016/j.jval.2012.08.1397
First page : A447
Section Title : Muscular-Skeletal Disorders
Open access? : No
Section Order : 894
Categories :
Tags :
Regions :
ViH Article Tags :